^sup 18^F-FDG PET/CT as a Sensitive and Early Treatment Monitoring Tool: Will This Become the Major Thrust for Its Clinical Application in Infectious and Inflammatory Disorders?/REPLY

摘要

[...] studies need to be increasingly undertaken, and the countries of the developing world, where the prevalence of this disease is relatively high, can play an active role. [...] we agree that the timing for follow-up imaging is unclear and should be revisited, even more so because common regimens adopted upfront after the diagnosis of tuberculosis are isoniazid, rifampicin, ethambutol, and pyrazinamide (HREZ) daily for 2 mo, followed by 4 mo of isoniazid and rifampicin (HR), or streptomycin, isoniazid, rifampicin, and pyrazinamide daily for 2 mo, followed by 4 mo of HR. Show less